Pharmafile Logo
Pharmafocus logo
Advanced Search

abortion

Showing 4 posts of 4 posts found.

An overview of women’s health in 2024

April 9, 2024
Reproductive health, abortion, fertility, reproductive health, women's health

Betsy Goodfellow from Pharmafocus considers the current landscape of women’s health, covering recent debates and ongoing issues within the reproductive health sphere …

Feature

US appeals court hears arguments in abortion pill case

May 18, 2023
Medical Communications Obstetrics & Gynaecology, abortion, medication abortion, mifepristone, reproduction

The ongoing court battle surrounding the contested approval of mifepristone, one of the drugs used in medication abortions, has now …

News
800px-us_supreme_court

US Supreme Court refuses Trump administration’s request to restrict delivery of abortion medication

October 9, 2020
Medical Communications abortion, abortion pill

The US Supreme Court has struck down a request from the Trump administration to restrict delivery of abortion medicine during …

News
800px-ted_cruz_39609752645

Ted Cruz and 19 other GOP Senators ask FDA to remove Danco’s abortion drug Mifeprex from the market

September 3, 2020
Manufacturing and Production Mifeprex, abortion

Texas Senator Ted Cruz and 19 other senators have sent a letter to the FDA urging them to take the …

News

Latest content

Sanofi shares results for phase 3 LUNA 3 trial in immune thrombocytopenia

April 23, 2024

FDA approves ImmunityBio’s Anktiva bladder cancer treatment

April 23, 2024

EC approves Pfizer’s Emblaveo for multidrug-resistant infection treatment

April 22, 2024

Neurolentech and Kaerus Bioscience enter partnership for research on neurodevelopmental disorder

April 22, 2024

Ardena announces €20m expansion following first GMP approval

April 19, 2024